Company Profile
CEO
Dr. Leonard S. Schleifer M.D., Ph.D.(Co-Founder, President, CEO & Co-Chairman)
Sector
Healthcare
Industry
Biotechnology
Employees
15.3K
Beta
0.24
Forward P/E
11.8
52W High
$821.11
52W Low
$476.49
Profit Margin
29.6%
Operating Margin
20.7%
Return on Equity
14.5%
Revenue Growth
19.0%
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and c...
Valuation
Market Cap$64.09B
P/E (TTM)14.93
P/S (TTM)4.44
EV/EBITDA20.60
Cash Flow
FCF Yield+5.3%
SBC Adj. FCF Yield+3.7%
SBC Impact30.3%
Margins & Growth
Profit Margin20.2%
Operating Margin17.8%
Revenue YoY19.0%
Earnings YoY-10.1%
Balance
Cash$2.96B
Debt$1.99B
Net Cash$976.40M
Dividend
Dividend Yield0.61%
Payout Ratio13.4%
Quarterly Payout$97.80M